Clinical Trial Update: Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma [NA]

View source ↗

Summary

This clinical trial update describes evaluating liver SUVmax-based criteria on 18F-FDG PET/CT to predict prognosis in patients with Peripheral T-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Lymphoma, T-Cell, Peripheral | NA | Status: UNKNOWN